Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China

Scandinavian Journal of Immunology

Volumn 72, Issue 1, 2010, Pages 50-56

  An, Y ^a   Xiao, J ^a   Jiang, L ^a   Yang, X ^a   Yu, J ^a,b   Zhao, X ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Division of Hematology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND;

ARTICLE; CHILD; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EXON; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HYPER IGM SYNDROME; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REMISSION; T LYMPHOCYTE ACTIVATION; X CHROMOSOME LINKED DISORDER;

ANTIGENS, CD40; BASE SEQUENCE; CD40 LIGAND; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; CYTIDINE DEAMINASE; DNA; FEMALE; FLOW CYTOMETRY; GENETIC VARIATION; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; INFANT; LEUKOCYTES, MONONUCLEAR; MALE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; URACIL-DNA GLYCOSIDASE;

EID: 77953330890     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02406.x     Document Type: Article

References (30)

1. Aruffo A, Farrington M, Hollenbaugh D et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993 72 : 291 300.
2. Fuleihan R, Ramesh N, Loh R et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A 1993 90 : 2170 2173. (Pubitemid 23078587)
3. Korthäuer U, Graf D, Mages HW et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993 361 : 539 541.
4. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 1993 361 : 541 543.
5. Winkelstein JA, Marino MC, Ochs H et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003 82 : 373 384.
6. Kutukculer N, Moratto D, Aydinok Y et al. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr 2003 142 : 194 196. (Pubitemid 36232912)
7. Ferrari S, Giliani S, Insalaco A et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM Proc Natl Acad Sci U S A 2001 98 : 12614 12619.
8. Minegishi Y, Lavoie A, Cunningham-Rundles C et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000 97 : 203 210.
9. Revy P, Muto T, Levy Y et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000 102 : 565 575.
10. Jacobs H, Bross L. Towards an understanding of somatic hypermutation. Curr Opin Immunol 2001 13 : 208 218.
11. Yamaoka S, Courtois G, Bessia C et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998 93 : 1231 1240.
12. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001 2 : 223 228.
13. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005 105 : 1881 1890.
14. Katz F, Hinshelwood S, Rutland P, Jones A, Kinnon C, Morgan G. Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat 1996 8 : 223 228.
15. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999 93 : 190 197.
16. Hollenbaugh D, Grosmaire LS, Kullas CD et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992 11 : 4313 4321.
17. Shimadzu M, Nunoi H, Terasaki H et al. Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome. Biochim Biophys Acta 1995 1260 : 67 72.
18. Notarangelo LD, Peitsch MC, Abrahamsen TG et al. CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996 17 : 511 516.
19. Van HoeyveldE, Zhang PX, De BoeckK, Fuleihan R, Bossuyt X. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. Immunology 2007 120 : 497 501.
20. Gilmour KC, Walshe D, Heath S et al. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. Mol Pathol 2003 56 : 256 262.
21. Seyama K, Nonoyama S, Gangsaas I et al. Mutations of the CD40 Ligand Gene and Its Effect on CD40 Ligand Expression in Patients With X-Linked Hyper IgM Syndrome. Blood 1998 92 : 2421 2434.
22. Kurtzberg J, Prasad VK, Carter SL et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008 112 : 4318 4327.
23. Prasad VK, Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant 2008 41 : 99 108.
24. Imai K, Catalan N, Plebani A et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 2003 112 : 136 142.
25. Bemark M, Sale JE, Kim HJ, Berek C, Cosgrove RA, Neuberger MS. Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J Exp Med 2000 192 : 1509 1514.
26. Casellas R, Nussenzweig A, Wuerffel R et al. Ku80 is required for immunoglobulin isotype switching. EMBO J 1998 17 : 2404 2411.
27. Wiesendanger M, Kneitz B, Edelmann W, Scharff MD. Somatic hypermutation in MutS homologue (MSH) 3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med 2000 191 : 579 584.
28. Ehrenstein MR, Neuberger MS. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J 1999 18 : 3484 3490.
29. Schrader CE, Vardo J, Stavnezer J. Mlh1 can function in antibody class switch recombination independently of Msh2. J Exp Med 2003 197 : 1377 1383.
30. Schrader CE, Vardo J, Stavnezer J. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J Exp Med 2002 195 : 367 373.